Walleye Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Walleye Capital’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-6,400	Closed	-$669K	–	1976
2019 Q4	$669K	Sell	6,400 -13,400	-68%	-$1.5M	0.04%	560
2019 Q3	$2.28M	Buy	19,800 +4,700	+31%	+$713K	0.14%	194
2019 Q2	$2.6M	Buy	15,100 +5,100	+51%	+$882K	0.29%	57
2019 Q1	$1.69M	Buy	+10,000	New	+$1.49M	0.28%	58

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Walleye Capital's GWPH Position: Q4 2019 in Review

Walleye Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 2,291 shares — an estimated $257K sold.

Walleye Capital first reported a position in GWPH in Q1 2019 and held it in 2 quarters. The position peaked at $264K in Q3 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

Walleye Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
Walleye Capital sold 2,291 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $257K.
Walleye Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 2 quarters.
Walleye Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $264K in Q3 2019.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on Walleye Capital's 13F filing for Q4 2019, filed 14 Feb 2020.